Has Christopher Atkinson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,388 in general payments to Christopher Atkinson, MD across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Atkinson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Atkinson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Atkinson, MD

Gastroenterology · Santa Fe, NMNPI 1093072027

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 35.8% of the total. That places this record below the midpoint for gastroenterology clinicians in NM, where the typical reported total is $1,418.

$1,388in general payments, 2019–2025

Across 70 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$497
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$193
Takeda Pharmaceuticals U.S.A., Inc.$137
Johnson & Johnson$135
Medtronic$128
Ardelyx, Inc.$109
plus $189 from 10 others

What the payments were for

Food & beverage$1,37299%
Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	32	$497
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	11	$193
Takeda Pharmaceuticals U.S.A., Inc.	5	$137
Johnson & Johnson	5	$135
Medtronic	2	$128
Ardelyx, Inc.	4	$109
Exelixis Inc.	2	$31
Sanofi	1	$25
UCB, Inc.	1	$21
Shire North American Group Inc	1	$19
Pfizer	1	$17
Echosens North America, Inc.	1	$17
Nestle Healthcare Nutrition Inc.	1	$16
Phathom Pharmaceuticals, Inc.	1	$16
Intercept Pharmaceuticals, Inc.	1	$14
Boston Scientific	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GI Genius$107

How this compares

$1,388 in reported general payments places this provider in the 45th percentile of 81 gastroenterology providers in New Mexico.

See all gastroenterology providers in New Mexico →

Medicare billing

Part B allowed, 2024

$136,799

Medicare patients

624

Services billed

1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg	446	$10,731
Omeprazole	156	$2,268
Budesonide DrBudesonide	13	$1,551
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	49	$951
Famotidine	34	$648
Pantoprazole Sodium	46	$506
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg	23	$422
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	18	$330
Spironolactone	12	$119
Furosemide	13	$41

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Santa Fe

Daniel BujandaSanta Fe$8K
Alejandra Castillo-RothSanta Fe$4K
Tomas ValerioSanta Fe$2K
Antoine JakicheAlbuquerque$108K
Fazia MirAlbuquerque$98K
Jean-Pierre ReinholdLas Cruces$79K
Christopher ChangAlbuquerque$51K
Stuart WeismanAlbuquerque$19K
Denis McCarthyAlbuquerque$17K
Kairasp NoshirwaniLas Cruces$10K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →